WG Consulting Opens Its First US Office and Appoints Charlotta Norgaard to Lead Its US Practice
NEW YORK, Aug. 1, 2012 /PRNewswire/ — WG Consulting — a world-leading market access consultancy — has opened its first US office in New York, providing on-the-ground strategic support to US-based pharmaceutical companies across all stages of the drug commercialization process. Delivering integrated market access insights and solutions, WG Consulting focuses on helping clients communicate brand value to clinical and payer stakeholders and drive optimal patient outcomes. WG has named Charlotta Norgaard to head its new US-based practice.
“With the Supreme Court upholding the Affordable Care Act, pharmaceutical companies will face radical changes in every aspect of their environment — from growing cost control pressures to stricter payer demands to new physician practice dynamics,” says Claire Gillis, CEO of WG. “During this turbulent time for our US customers, we thought it was critical to offer local experts who can work hand in hand with them, guiding them safely through a volatile landscape. With WG’s deep global experience, we can help our US clients leverage the lessons learned across Europe, so they can capitalize on the successes and avoid the mistakes of countries that have gone through similar transitions.
“Bringing a rich background in market access and reimbursement consulting, Charlotta Norgaard is the ideal partner for our American clients. Committed to ensuring her clients achieve their goals, she will help them build strategic plans and messaging that drive success in today’s payer-dominated, value-driven market.”
“I am thrilled to be part of the WG team as it expands its presence in the US,” adds Ms. Norgaard. “WG stands alone in its ability to align clinical data, health economics outcomes research and payer analytics across the entire marketing process. In addition, as part of ghg and the WPP family, we can tap into a worldwide network of communications agencies, market research firms and insights companies, leveraging an unrivalled range of resources and talent to support our clients’ objectives.”
Ms. Norgaard Bring Extensive Healthcare Consulting Experience to WG Consulting
Ms. Norgaard comes to WG Consulting from QD Healthcare in Stamford, CT, where she created and led a market access division. Prior to QD, she ran her own consulting business, focused on access and reimbursement business strategy, process improvement and project management.
Before starting her own firm, Ms. Norgaard served as Director of Access Solutions for Quorum Consulting in San Francisco, CA. At Quorum, she directed reimbursement efforts and bi-coastal call center operations. She also managed an array of key projects around drug launch plans, reimbursement, clinical trial and drug support services, payer and coverage policies and physician outreach.
Ms. Norgaard started her healthcare career at Genentech in San Francisco. Her responsibilities included creating and managing reimbursement call centers, specialty pharmacy distribution channels and market access teams for new product launches.
A passionate patient advocate, Ms. Norgaard has been actively involved in patient assistance and free drug programs, drug hotline call centers and payer relations. In addition, she has worked to break down reimbursement barriers, ensuring patients gain access to therapy.
Born and raised in Denmark, Ms. Norgaard hold a BA in business. She also has a business certificate from Vista College in conjunction with the University of California, Berkeley.
Free Webinar Will Share New ACA (Affordable Care Act) Research
As a service to the healthcare industry, WG Consulting is sponsoring a new, educational webinar, Building Winning Strategies in an ACA World: Your Guide to Success in a Value-Driven Market. Scheduled for September 20 from 11:00 am to 12:00 pm ET, the session will reveal the results of new research on how payers, patients and pharmaceutical companies are reacting to and planning for ACA — and how their responses compare to consumers. Registration is free at www.pharmavoice.com/ACA.
About WG Consulting…
WG Consulting (www.wg-group.com), part of the ghg network, is a global, evidence-based, best-in-class market access consultancy, aligning clinical, HEOR and payer analytics across all therapeutic categories and every stage of drug commercialization. We provide value-driven, integrated market access solutions and guidance, helping clients effectively communicate brand value to clinical and payer stakeholders and optimize patient outcomes. A worldwide leader, WG recently opened its first US office at 114 Fifth Avenue in New York.